HEPARIN
Pancreatic Beta Cell Function
University Health Network, TorontomixturePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Pancreatic Beta Cell Function cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Intralipid University Health Network, Toronto | Phase 4 | BB |
N-Acetyl-L-Cysteine University Health Network, Toronto | Phase 4 | BB |
Same molecule, other indications
HEPARIN is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →